ConductScience.org, home

Gene · 3205

Papers4,255

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

561 to 580 of 4,255

Download this page as JSON
TitleJournalYearPMIDFound bySource
Adoptive Immunotherapy: A Human Pluripotent Stem Cell Perspective.Cells Tissues Organs202336599319PubTator, text miningPubMed
A comprehensive landscape of transcription profiles and data resources for human leukemia.Blood Adv202336595475PubTator, text miningPubMed
DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax.
Theranostics202336593968PubTator, text miningPubMed
Antigen-specific TCR-T cells from Rag2 gene-deleted pluripotent stem cells impede solid tumour growth in a mouse model.Cell Prolif202336592612PubTator, text miningPubMed
Role of microRNAs regulating trophoblast cell function in the pathogenesis of pre‑eclampsia (Review).Exp Ther Med202336588809PubTator, text miningPubMed
Novel biological insights revealed from the investigation of multiscale genome architecture.Comput Struct Biotechnol J202336582436PubTator, text miningPubMed
HOXA9 forms a repressive complex with nuclear matrix-associated protein SAFB to maintain acute myeloid leukemia.Blood202336577137PubTator, text miningPubMed
Nuclear factor I-C overexpression promotes monocytic development and cell survival in acute myeloid leukemia.Leukemia202336572750PubTator, text miningPubMed
A pro B cell population forms the apex of the leukemic hierarchy in Hoxa9/Meis1-dependent AML.Leukemia202336517672PubTator, text miningPubMed
Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid Leukemia.Cancer Discov202336455613PubTator, text miningPubMed
Mutant NPM1 Hijacks Transcriptional Hubs to Maintain Pathogenic Gene Programs in Acute Myeloid Leukemia.Cancer Discov202336455589PubTator, text miningPubMed
IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia.EMBO Mol Med202336453131PubTator, text miningPubMed
Repurposing immunosuppressants for antileukemia therapy.EMBO Mol Med202336453114PubTator, text miningPubMed
Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives.Cancer Commun (Lond)202336424360PubTator, text miningPubMed
P2X1 enhances leukemogenesis through PBX3-BCAT1 pathways.Leukemia202336418376PubTator, text miningPubMed
Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML).Leukemia202336411356PubTator, text miningPubMed
Cell-scaffold interactions in tissue engineering for oral and craniofacial reconstruction.Bioact Mater202336406245PubTator, text miningPubMed
The prognostic role of C-KIT, TET1 and TET2 gene expression in Acute Myeloid Leukemia.Mol Biol Rep202336371552PubTator, text miningPubMed
Propofol inhibits glioma progression by regulating circMAPK4/miR-622/HOXA9 axis.Metab Brain Dis202336326978PubTator, text miningPubMed
EVI1 exerts distinct roles in AML via ERG and cyclin D1 promoting a chemoresistant and immune-suppressive environment.Blood Adv202336269819PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3205/papers?page=29